PNC FINANCIAL SERVICES GROUP, INC. - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$2,266,617
-34.2%
59,088
+0.8%
0.00%0.0%
Q1 2024$3,445,096
-52.0%
58,610
-51.1%
0.00%
-66.7%
Q4 2023$7,170,331
+57.4%
119,785
+0.0%
0.01%
+50.0%
Q3 2023$4,554,910
-59.1%
119,740
-2.1%
0.00%
-55.6%
Q2 2023$11,146,177
+174.9%
122,351
+99.1%
0.01%
+125.0%
Q1 2023$4,054,232
+28.6%
61,465
+0.8%
0.00%
+33.3%
Q4 2022$3,151,983
-20.4%
60,955
+5.2%
0.00%
-25.0%
Q3 2022$3,958,000
+51.5%
57,946
+0.3%
0.00%
+33.3%
Q2 2022$2,612,000
-10.9%
57,752
+0.1%
0.00%0.0%
Q1 2022$2,932,000
+379.1%
57,699
+345.6%
0.00%
+200.0%
Q4 2021$612,000
+206.0%
12,948
+113.7%
0.00%
Q3 2021$200,000
-46.8%
6,058
+1.8%
0.00%
Q2 2021$376,000
+47.5%
5,9480.0%0.00%
Q1 2021$255,000
-25.0%
5,9480.0%0.00%
Q4 2020$340,000
+89.9%
5,9480.0%0.00%
Q3 2020$179,000
+9.1%
5,948
+18.8%
0.00%
Q2 2020$164,000
+22.4%
5,008
+0.2%
0.00%
Q1 2020$134,000
-13.0%
5,0000.0%0.00%
Q4 2019$154,000
-26.7%
5,000
-42.9%
0.00%
Q3 2019$210,000
-16.3%
8,760
-11.2%
0.00%
Q2 2019$251,000
-9.1%
9,860
-30.3%
0.00%
Q1 2019$276,000
+122.6%
14,140
+50.7%
0.00%
Q4 2018$124,0000.0%9,380
+35.2%
0.00%
Q3 2018$124,000
-23.5%
6,940
-6.0%
0.00%
Q2 2018$162,0007,3800.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 624,962$20,599,00013.29%
Octagon Capital Advisors LP 1,595,911$52,601,00012.95%
Logos Global Management LP 1,450,000$47,792,0003.45%
Avoro Capital Advisors LLC 5,000,000$164,800,0002.59%
Ghost Tree Capital, LLC 200,000$6,592,0001.93%
Integral Health Asset Management, LLC 190,000$6,262,0001.80%
GREAT POINT PARTNERS LLC 200,000$6,592,0001.54%
Aufman Associates Inc 53,642$1,768,0001.45%
Ghost Tree Capital, LLC 150,000$4,944,0001.45%
Altium Capital Management LP 166,700$5,494,0001.44%
View complete list of APELLIS PHARMACEUTICALS INC shareholders